Business
Astrana Health, Inc. Reports Fourth Quarter and Year-End 2024 Results
Company to Host Conference Call on Thursday, February 27, 2025, at 2:30 p.m. PT/5:30 p.m. ET ALHAMBRA, Calif., Feb. 27, 2025 /PRNewswire/ -- Astrana Health,
About this update from Astrana Health Inc.
[{"type":"text","content":"Company to Host Conference Call on Thursday, February 27, 2025, at 2:30 p.m. PT/5:30 p.m. ET\nALHAMBRA, Calif., Feb. 27, 2025 /PRNewswire/ -- Astrana Health, Inc. (\"Astrana,\" and together with its subsidiaries and affiliated entities, the \"Company\") (NASDAQ: ASTH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced its consolidated financial results for the fourth quarter and year ended December 31, 2024.\n\n \n \n \n \n \n \n\n \n\"Astrana Health's strong performance in 2024 highlights the strength of our patient-centered, payer-agnostic platform and our unwavering commitment to delivering high-quality, accessible care. Our significant growth and geographic expansion, alongside robust financial performance, are a direct result of our disciplined execution across the four pillars of the Astrana playbook, \" said President and CEO of Astrana, Brandon K. Sim.\n\"Looking ahead, we remain focused on growing membership sustainably, further improving quality of care for our membership while responsibly managing costs, growing the 73% of our capitated revenue that now comes from full-risk arrangements, and driving operating leverage and integration of recently acquired assets. We are confident that our platform, combined with our proven ability to navigate industry headwinds and a favorable outlook on future reimbursement rates, will continue delivering sustainable, long-term value for all our stakeholders - patients, physicians, providers, payers, and shareholders.\"\nFinancial Highlights for Year Ended December 31, 2024:\nAll comparisons are to the year ended December 31, 2023 unless otherwise stated.\nTotal revenue of $2,034.5 million, up 47% from $1,386.7 millionCare Partners revenue of $1,949.0 million, up 52% from $1,284.1 millionNet income attributable to Astrana of $43.1 million, compared to $60.7 millionEarnings per share - diluted (\"EPS - diluted\") of $0.90, compared to $1.29 per shareAdjusted EBITDA(1) of $170.4 million, up 16% from $146.6 million(1) See \"Reconciliation of Net Income to EBITDA, Adjusted EBITDA and Adjusted EBITDA Margin\" and \"Use of Non-GAAP Financial Measures\" below for additional information.\nFinancial Highlights for the Fourth Quarter 2024:\nAll comparisons are to the quarter ended...